Mitoxantrone and cardiomyopathy Patient Reports February 12, 2012



Mitoxantrone Side Effects Report #4805103-5
Mitoxantrone side effect was reported by a Physician from GERMANY on Sept 29, 2005. Male patient, 24 years of age, was diagnosed with multiple sclerosis What is  multiple sclerosis and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: cardiomyopathy What is  cardiomyopathy, ejection fraction decreased, white blood cell count decreased. Mitoxantrone dosage: 12 MG/M2. Patient recovered.

Mitoxantrone Side Effects Report #4847584-7
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Nov 18, 2005. Female patient was diagnosed with multiple sclerosis What is  multiple sclerosis and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: cardiomyopathy What is  cardiomyopathy, ventricular dysfunction. Mitoxantrone dosage: 12 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS. Patient recovered.

Mitoxantrone Side Effects Report #5369889-6
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: cardiomyopathy What is  cardiomyopathy, torsade de pointes. Mitoxantrone dosage: unknown. During the same period patient was treated with ARSENIC TRIOXIDE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #5369890-2
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, 16 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: arrhythmia What is  arrhythmia, cardiomyopathy What is  cardiomyopathy, disease recurrence, hypokalaemia, left ventricular dysfunction, pulmonary haemorrhage, torsade de pointes. Mitoxantrone dosage: unknown. During the same period patient was treated with ACLARUBICIN, DOXORUBICIN. Patient was hospitalized. Patient died.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Mitoxantrone